XZC-20390-34498
5 vaccinations
5 coded responses
62 check-ins
5 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 494 / MI
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Pfizer-BioNTech
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
-
2021-02-10
Survey response — 14 day, dose 1MedDRA: Fatigue, Oropharyngeal pain, Sinus congestion — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-02-17
Dose 2 — Pfizer-BioNTech
- 2021-02-17
-
2021-02-18
Survey response — days 1–6 daily, dose 2MedDRA: Eye swelling, Ocular hyperaemia — Feeling: Good · Site: Pain · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-05-19
- 2021-08-18
-
2021-09-30
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-12-30
- 2022-03-31
-
2022-04-07
Dose 4 — Pfizer-BioNTech
-
2022-04-08
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-04-09
- 2022-04-10
- 2022-04-11
- 2022-04-12
- 2022-04-13
- 2022-04-14
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-05-12
-
2022-05-19
Survey response — 42 day, dose 4MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
- 2022-07-07
-
2022-09-16
Dose 5 — Pfizer-BioNTech
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
-
2022-10-21
Survey response — 35 day, dose 5MedDRA: Fatigue, Oropharyngeal pain, Sinus congestion — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2022-10-21
Report sent to call center — 35 day, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-24
-
2022-10-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-28
Survey response — 42 day, dose 5MedDRA: Laboratory test abnormal, Quarantine — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2022-10-28
Report sent to call center — 42 day, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-11-02
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-12-16
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-17 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-04-07 | Pfizer-BioNTech | No |
| 5 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-21 | Successful 2022-10-24 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-10-28 | Successful 2022-11-02 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 4
Symptoms: Mild sore throat for 24 hours with a little sinus congestion and a little fatigue.
Systemic reaction (other): Slight swelling and redness around my eyes starting 2 hours after vaccination. Never serious. Slowly going away today.
Release 11
Symptoms: Felt Unusually fatigued yesterday and today.
Release 12
Symptoms: Sinus congestion, slight sore throat, and slight fatigue.
Symptoms: Tested positive on 10/14/2022, took Paxlovid, isolated for 5 days, tested negative, masked for another 5 days, tested negative, tested positive again 4 days later on 10/27/2022.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Quarantine | · | · | ✓ |
| SD | Sinus congestion | ✓ | ✓ | ✓ |
| SRO | Eye swelling | ✓ | ✓ | ✓ |
| SRO | Ocular hyperaemia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release